Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
Become a Member | Sign in

  News Archive

UK Strategic Plan for Synthetic Biology 2016 Released
Thursday, February 25, 2016
Minister for Life Sciences George Freeman MP will today visit SynbiCITE at Imperial College London, the UK innovation and knowledge centre for synthetic biology, to announce the release of the UK Synthetic Biology Strategic Plan 2016 — Biodesign for the Bioeconomy.

Recombinase BREC1 Trend-Setting for Future HIV-Therapy
Thursday, February 25, 2016
Researchers at the Medical Faculty of the Technische Universität Dresden (TUD) and the Heinrich Pette Institute (HPI), Leibniz Institute for Experimental Virology succeeded in developing a designer recombinase (Brec1) that is capable of specifically removing the provirus from infected cells of most primary HIV-1 isolates.

Powerful Drug for Familial Amyloidosis
Thursday, February 25, 2016
The molecule has proved in preclinical trials to be up to four times more effective than the only pharmacological treatment currently available for familial transthyretin amyloidosis, a rare degenerative disease, and has already been tested in a clinical trial with patients.

Cobra Biologics, CPI Announce Collaboration
Thursday, February 25, 2016
Cobra Biologics and the Centre for Process Innovation are collaborating on a project which will focus on the development of an Industrial Manufacturing Platform for Adeno-Associated Virus (AAV) production to support gene therapy and regenerative medicine.

Vaccine Fridge Field Study ‘Opens Doors’ to New Standards
Wednesday, February 24, 2016
Recipients of an annual flu shot may be surprised to learn that there is currently no official standard for vaccine storage equipment in clinics, pharmacies, and other health providers’ offices – a potential problem, since vaccines need to be kept within strict temperature limits to remain viable.

HIV Modification May Put a Twist on Vaccine and Drug Design
Wednesday, February 24, 2016
Crucial HIV RNA modification called m6A influences viral replication, but wasn’t previously taken into consideration when developing anti-HIV therapies.

Affinivax Secures Additional Funding to Advance Its Novel Pneumococcal Vaccine Towards Clinical Trials
Tuesday, February 23, 2016
Company has announced receipt of a $2.5 million investment from the Gates Foundation for MAPS vaccine targeting Streptococcus pneumoniae (pneumococcus) towards clinical testing.

VBI Vaccines Announces Research Collaboration with GlaxoSmithKline
Tuesday, February 23, 2016
Company has announced collaboration with GlaxoSmithKline to enhance vaccine stability and evaluate VBI’s LPV™ Platform.

Geovax to Develop Vaccine Against Zika Virus
Tuesday, February 23, 2016
Company has announced that it has begun a program to develop a vaccine for the prevention of Zika virus infection.

<< 6 7 8 9 10 11 12 >>
Showing Results 81 - 90 of 1883

SELECTBIO Market Reports
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,400+ scientific videos